Non-HDL-C to LDL Ratio Risk Index Calculator

Non-HDL-C to LDL-C Ratio: Explanation and Clinical Context The Non-HDL-C to LDL-C ratio represents the proportion of total atherogenic lipoproteins (all apoB-containing particles) relative to LDL cholesterol. While LDL-C has long been the cornerstone of lipid management, non-HDL-C provides a more comprehensive view of atherogenic burden, encompassing VLDL, IDL, and lipoprotein(a). Definition: Non-HDL-C is calculated as Total Cholesterol minus HDL-C.

The Non-HDL-C to LDL-C ratio quantifies the contribution of non-LDL atherogenic lipoproteins relative to LDL-C. Normal Value: A Non-HDL-C/LDL-C ratio typically ranges from 1.0 to 1.4 in healthy adults. Ratios above 1.6 are linked to greater small dense LDL particles and residual cardiovascular risk even in patients with LDL-C within target range.

Clinical Significance: Several studies have demonstrated that the Non-HDL-C/LDL-C ratio correlates more strongly with carotid intima-media thickness (CIMT), coronary artery calcification, and incident atherosclerotic cardiovascular disease (ASCVD) than LDL-C alone. It serves as a simple yet powerful biomarker for residual dyslipidemia, particularly in individuals with diabetes, obesity, or metabolic syndrome. Clinical Interpretation Summary: A higher Non-HDL-C/LDL-C ratio suggests a lipid profile rich in triglyceride-rich remnants and other atherogenic particles.

Monitoring this ratio may guide intensification of lipid-lowering therapy (e.g., addition of ezetimibe or PCSK9 inhibitor) beyond LDL-C–based targets.